Replies to post #2335 on Enanta Pharmaceuticals Inc (ENTA)

[vinmantoo]

So with expenses going up $50-75MM and revenue weak, it is possible for $175-200MM (or higher) loss in next 12 months. Sounds like they might need to raise more money sooner than later.

The markets seems to agree with you. The long projected timeline for EDP-235 and no announcement on a second anti-HBV drug may also be weighing on ENTA stock price.

[DewDiligence]

ENTA will presumably seek some up-front cash when they partner EDP-235 following phase-2 (assuming the data are positive).